1. Two surface antigens, CD23 (p45) and a novel p50 molecule, deliver distinct progression signals to activated B lymphocytes;Gordon,1987
2. Activation of human B cells mediated through two distinct cell surface differentiation structures, Bp35 and Bp50;Clark,1986
3. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes;Paulie;Cancer Immunol Immunother,1985
4. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas;Stamenkovic;EMBO J,1989
5. Katira A, Holder M, Pound J, Gordon J. CD40 Workshop Panel Report. In: Leukocyte Typing V. Schlossman S F et al (eds). Oxford University Press, Oxford (in press).